Irene Santos‐Pardo

发表

Heart rate variability in type 2 diabetic subjects randomized to liraglutide or glimepiride treatment, both in combination with metformin: A randomized, open, parallel‐group study

X. Fang, J. Jendle, Yang Cao, 2019, Endocrinology, diabetes & metabolism.

Index of Microcirculatory Resistance Measured during Intracoronary Adenosine-Induced Hyperemia

N. Witt, P. Alström, Irene Santos‐Pardo, 2020, Journal of interventional cardiology.

The MOVEMENT Trial

Ulf J Jensen, J. van der Linden, P. Tornvall, 2019, Journal of the American Heart Association.

Autoimmunity and atrioventricular block of unknown etiology in adults: the role of anti-Ro/SSA antibodies.

A. Bayés‐Genís, G. Juncà, A. Olivé, 2014, Journal of the American College of Cardiology.

Anti-Ro/SSA antibodies and cardiac rhythm disturbances: Present and future perspectives.

A. Bayés‐Genís, A. Olivé, R. Villuendas, 2015, International journal of cardiology.

Anti-Ro antibodies and reversible atrioventricular block.

A. Bayés‐Genís, R. Villuendas, M. Martínez-Morillo, 2013, The New England journal of medicine.

Rational and design of the European randomized Optical Coherence Tomography Optimized Bifurcation Event Reduction Trial (OCTOBER)

F. Burzotta, S. Walsh, P. Knaapen, 2018, American heart journal.

Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study

L. Bojö, J. Jendle, Yang Cao, 2017, Front. Endocrinol..

Risk of stent failure in patients with diabetes treated with glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors: A nationwide observational study.

N. Witt, V. Ritsinger, B. Lagerqvist, 2021, International journal of cardiology.